Return to listing
Stamford, Conn. – April 29, 2014 – AmeriCares and the Boehringer Ingelheim Cares Foundation are launching a new program that will provide a free supply of medication to more than 3,000 eligible uninsured Americans. Boehringer Ingelheim has committed to producing a portfolio of critically needed medicines that will be distributed by AmeriCares to free clinics in Connecticut, Florida, West Virginia, Texas and Ohio.
Beginning this month, patients suffering from hypertension, chronic respiratory problems and infections may receive a supply of Boehringer Ingelheim medicines free of charge. Approximately 2,500 hypertension patients and nearly 1,200 patients with chronic obstructive pulmonary disease (COPD) are expected to benefit. In the four Connecticut clinics alone, the new program will provide treatment for approximately 600 patients diagnosed with hypertension.
The medicines will be distributed through AmeriCares U.S. Medical Assistance Program, which provides donated medicines, vaccines and medical supplies to free clinics, community health centers and health departments nationwide. AmeriCares is the nation’s largest provider of donated medical aid to the U.S. health care safety net, last year delivering $70 million in prescription and over-the-counter medicines and medical supplies for patients in need. The donated Boehringer Ingelheim medicines will allow safety net clinics to increase capacity, provide comprehensive care, improve health outcomes and reduce costs for patients.
“Boehringer Ingelheim Cares Foundation is committed to improving access to healthcare with a focus on underserved patients,” said Lilly Ackley, President, Boehringer Ingelheim Cares Foundation. “This new program with our valued partner, AmeriCares, is our latest way to accomplish this goal.”
According to recent White House data, more than 8 million Americans have signed up for health insurance under the Affordable Care Act. This still leaves tens of millions of Americans outside the healthcare system.
“Boehringer Ingelheim has long been one of our most generous pharmaceutical donors and now they have taken their commitment one step further by manufacturing products specifically for Americans in need,” said AmeriCares President and CEO Michael J. Nyenhuis. “Together we will improve the health of more than 3,000 poor and uninsured Americans suffering from chronic hypertension and COPD.”
Boehringer Ingelheim has been an AmeriCares partner for more than 20 years, donating $226 million in products for people in need in over 100 countries. The pharmaceutical company is also a longtime supporter of the Boehringer Ingelheim AmeriCares Free Clinic in Danbury, Connecticut.